We are live on ! Find out more
BCAB icon

BioAtla
BCAB

73 hedge funds and large institutions have $208M invested in BioAtla in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more call options, than puts

Call options by funds: $3.34M | Put options by funds: $726K

211% more capital invested

Capital invested by funds: $67.1M → $208M (+$141M)

0.18% more ownership

Funds ownership: 1.31% → 1.49% (+0.18%)

9% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 22

4% less funds holding

Funds holding: 76 → 73 (-3)

12% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 25

Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
20
Reduced
22
Closed
25
Calls
$3.34M
Puts
$726K
Net Calls
+$2.61M
Net Calls Change
+$2.67M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$13.2M
2
CS
Candriam SCA
Luxembourg
+$10M
3
EAM
Eventide Asset Management
Massachusetts
+$5.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.01M
5
ACA
Avoro Capital Advisors
New York
+$3.76M

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$9.2M
2
RCM
RA Capital Management
Massachusetts
-$2.94M
3
BBA
Baker Bros. Advisors
New York
-$2.35M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.94M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
51
HighTower Advisors
Illinois
$100K – – –
Jane Street
52
Jane Street
New York
$98K -$69.7K -213 -46%
DekaBank Deutsche Girozentrale
53
DekaBank Deutsche Girozentrale
Germany
$95K +$81.8K +250 New
Qube Research & Technologies (QRT)
54
Qube Research & Technologies (QRT)
United Kingdom
$92K -$22.3K -68 -22%
Man Group
55
Man Group
United Kingdom
$90K +$76.3K +233 New
SS
56
Simplicity Solutions
Minnesota
$78K +$655 +2 +1%
TLCM
57
Twin Lakes Capital Management
California
$69K +$58.9K +180 New
DA
58
Denali Advisors
California
$56K +$47.8K +146 New
UBS Group
59
UBS Group
Switzerland
$43K +$36.7K +112 New
Citigroup
60
Citigroup
New York
$18K +$6.22K +19 +66%
Simplex Trading
61
Simplex Trading
Illinois
$17K -$139K -424 -90%
TRCT
62
Tower Research Capital (TRC)
New York
$15K -$20.3K -62 -61%
Barclays
63
Barclays
United Kingdom
$14K +$3.27K +10 +36%
IA
64
IFP Advisors
Florida
$6K – – –
CA
65
Crewe Advisors
Utah
$3K – – –
CUAMC
66
China Universal Asset Management Company
China
$3K +$2.29K +7 New
PHK
67
Point72 Hong Kong
Hong Kong
$3K +$2.62K +8 New
Daiwa Securities Group
68
Daiwa Securities Group
Japan
$1K – – –
Wells Fargo
69
Wells Fargo
California
$1K +$327 +1 +25%
RCM
70
RA Capital Management
Massachusetts
– -$2.94M -20,636 Closed
BBA
71
Baker Bros. Advisors
New York
– -$2.35M -16,500 Closed
D.E. Shaw & Co
72
D.E. Shaw & Co
New York
– -$614K -4,312 Closed
HF
73
HRT Financial
New York
– -$417K -2,932 Closed
MA
74
MYDA Advisors
New York
– -$211K -1,480 Closed
E
75
Ergoteles
New York
– -$202K -1,416 Closed
1 2
3
4

BCAB Hedge Fund Activity: Q3 2022 in Review

73 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q3 2022, worth a combined $208M — up 211% from $67.1M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of BCAB and 22 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 20 added.

The largest buyer was Janus Henderson Group, adding an estimated $13.2M. The largest seller was Tang Capital Management, cutting an estimated $9.2M.

  • 73 institutional investors held BioAtla (BCAB) as of Q3 2022, down from 76 in Q2 2022.
  • Funds reported $208M of BioAtla stock for Q3 2022, up 211% quarter-over-quarter.
  • 22 funds opened new BioAtla positions in Q3 2022 and 25 closed out, a net change of -3 holders.
  • The largest BioAtla buyer in Q3 2022 was Janus Henderson Group, an estimated $13.2M added.
  • The largest BioAtla seller in Q3 2022 was Tang Capital Management, an estimated $9.2M sold.

Based on aggregated 13F filings for Q3 2022.